×

Transcriptional regulatory fusion polypeptide

  • US 11,390,652 B2
  • Filed: 12/11/2017
  • Issued: 07/19/2022
  • Est. Priority Date: 12/12/2016
  • Status: Active Grant
First Claim
Patent Images

1. A fusion polypeptide comprising:

  • a cell-penetrating peptide;

    a DNA-binding polypeptide that binds to the nucleotide sequence represented by SEQ ID NO;

    49; and

    a transcriptional activator, wherein the cell-penetrating peptide, the DNA-binding peptide and the transcriptional activator are in this order from the N-terminal side.

View all claims
  • 3 Assignments
Timeline View
Assignment View
    ×
    ×